-
Genomic Testing for Early Breast Cancer: Assessing the Value of Next-Generation Sequencing
Sep 9, 2025, 16:22 PM -
Improving Data Quality in Oncology Electronic Health Record (EHR)-Derived Databases for Research and Regulatory Decision Making
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Ovarian Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
Cost Comparison of Alternative Delivery Routes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) in the English National Health Service (NHS)
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Costs Among Bacillus Calmette-Guérin (BCG)-Experienced or Unresponsive Patients With Papillary-Only High-Risk Non–Muscle Invasive Bladder Cancer
Sep 9, 2025, 16:22 PM -
How Are Clinical Trials for Breast Cancer Treatments Currently Being Designed? A Clinical Trial Database Analysis
Sep 9, 2025, 16:22 PM -
Cost and Healthcare Resource Utilization Associated With Chronic Inducible Urticaria: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
The Next Steps Matter? New Cancer Medicines and Their Indication Extensions in Europe 2010-2020
Sep 9, 2025, 16:22 PM -
Bimekizumab Cost per Responder Analysis Compared to Other Licensed Interleukin Inhibitors at Week 52 for the Treatment of Psoriatic Arthritis: A United Kingdom Perspective
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Artificial Intelligence Interventions for Musculoskeletal Disorders: Systematic Review
Sep 9, 2025, 16:22 PM -
From Cost Containment to Modernization: Market Access Updates Across the EU4 and the UK in 2025
Sep 9, 2025, 16:22 PM -
Real-World Costs of United States Patients With T1 Diabetes, Removing Misdiagnosed Patients, and Compared With Patients With T1D and (T1.5 or T2) Diabetes
Sep 9, 2025, 16:22 PM -
A Cost-Utility Analysis of Ferric Derisomaltose vs. Ferric Carboxymaltose in Patients with Iron Deficiency Anemia and Inflammatory Bowel Disease in the United Kingdom: Accounting for Difference in Fracture Risk
Sep 9, 2025, 16:22 PM -
Evaluating the Role of Disease-Specific Patient-Reported Outcomes in HTA Submissions for Rare Conditions: A Comparative Case Study of Narcolepsy and Phenylketonuria
Sep 9, 2025, 16:22 PM -
Can Generative AI Automate Health Economic Model Verification?
Sep 9, 2025, 16:22 PM -
The Role of Qualitative Research in Randomized Controlled Trials Involving Drugs and Medical Devices: A Systematic Mapping Review
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Inclisiran for the Management of Patients With Atherosclerotic Cardiovascular Disease in India: A Multipayer Analysis
Sep 9, 2025, 16:22 PM -
Requirements for Payer Recognition of Disease-Modifying Effect in New Drug Launches
Sep 9, 2025, 16:22 PM -
Human Alignment on Evaluating LLMs for Literature Review Extraction
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Ga-PSMA-11 PET/CT Imaging Followed by Lu-PSMA-617 vs. Standard of Care in Metastatic Castrate-Resistant Prostate Cancer
Sep 9, 2025, 16:22 PM
